Not applicableUnknownNCT05288569What this trial is testingIrAE Prediction of Anti-PD-1/L1 in Lung CancerWho this might be right forImmune Checkpoint InhibitorsLung Cancer Peking Union Medical College Hospital 120
Not applicableLooking for participantsNCT07354971What this trial is testingIMMUNO-FIT Observational StudyWho this might be right forNeoplasmsImmunotherapyPhysical Fitness+2 more University Hospital Southampton NHS Foundation Trust 67
Not applicableLooking for participantsNCT05139706What this trial is testingMontreal Immune-Related Adverse Events (MIRAE) StudyWho this might be right forCancerImmune System DisorderInflammatory Reaction+1 more Sir Mortimer B. Davis - Jewish General Hospital 1,000
Testing effectiveness (Phase 2)Temporarily pausedNCT06254911What this trial is testingPre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal CarcinomaWho this might be right forOropharynx Cancer, Stage I Emory University 20
Not applicableLooking for participantsNCT07249060What this trial is testingInterferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease PatientsWho this might be right forImmune-Related Adverse EventsLupus Erythematosus, SystemicSjogren Syndrome+3 more Hospital Universitario Araba 300
Not applicableUnknownNCT05426317What this trial is testingExploratory Interventional Study of Prognostic Serum Biomarkers of Cancer ProgressionWho this might be right forMelanomaNon Small Cell Lung CancerRenal Cancer University Hospital, Clermont-Ferrand 100
Not applicableLooking for participantsNCT06915389What this trial is testingMetabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer PatientsWho this might be right forGastric CancerImmunotherapyAdverse Event+2 more Qinghai Red Cross Hospital 100
Not applicableUnknownNCT04268368What this trial is testingImmune Related-adverse Events in Patients Receiving Immune Checkpoint InhibitorsWho this might be right forCancerLung CancerRenal Cell Carcinoma+1 more Università Politecnica delle Marche 200
Testing effectiveness (Phase 2)Study completedNCT05535569What this trial is testingPhase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric CancerWho this might be right forRecurrent/Metastatic Gastric Cancer Yonsei University 50
Not applicableActive Not RecruitingNCT06876402What this trial is testingGene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)Who this might be right forNSCLC (Non-small Cell Lung Cancer) Hellenic Cooperative Oncology Group 367
Not applicableNot Yet RecruitingNCT07331701What this trial is testingAssociation of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational StudyWho this might be right forLung NeoplasmsTumor Immune Microenvironment Seoul National University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03082534What this trial is testingPembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forHNSCCLip SCCOral Cavity Cancer+9 more University of California, San Diego 78
Not applicableLooking for participantsNCT07485114What this trial is testingAssociation Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 InhibitorsWho this might be right forRenal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular Carcinoma+1 more Daniel Keizman 300
Not applicableNot Yet RecruitingNCT06613308What this trial is testingAssociation Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLCWho this might be right forLung Cancer (NSCLC) Capital Medical University 20
Not applicableUnknownNCT05819905What this trial is testingRadiomics for prEdiction of lunG cAncer biologYWho this might be right forNon Small Cell Lung CancerPET/CTPD-L1+1 more Poitiers University Hospital 600
Post-approval studies (Phase 4)Temporarily pausedNCT04036721What this trial is testingCoorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced PneumonitisWho this might be right forLung Neoplasm MalignantInterstitial Lung Disease National Institute for Tuberculosis and Lung Diseases, Poland 85
Not applicableStudy completedNCT05387512What this trial is testingReal-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Affiliated Hospital of Nantong University 60
Early research (Phase 1)Ended earlyNCT04958434What this trial is testingStudy of TST005 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic CancersMetastatic Human Papillomavirus-Related Malignant Neoplasm Suzhou Transcenta Therapeutics Co., Ltd. 19
Not applicableNot Yet RecruitingNCT07198958What this trial is testingImmune Adverse Events Registry in Onco-Hematologic Patients Treated With ImmunotherapyWho this might be right forCancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Cancer (Solid Tumors)+1 more IRCCS San Raffaele 500
Testing effectiveness (Phase 2)Ended earlyNCT03451773What this trial is testingM7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the PancreasWho this might be right forCancer of PancreasPancreas CancerPancreatic Adenocarcinoma+2 more National Cancer Institute (NCI) 7